Aurobindo Pharma is trading higher by 2% to Rs 626 after MSCI added the pharmaceutical company to MSCI India index with effect from May 30.
The stock opened at Rs 624 and touched a new high of Rs 633 on the NSE. A combined 340,000 shares changed hands on the counter in early morning deals on the NSE and BSE.
MSCI added Aurobindo Pharma to the MSCI India index after its semi-annual global index review, a Reuters report suggests.
The index provider also added 13 stocks and deleted the same number from MSCI global small-cap indexes, it added.
The stock opened at Rs 624 and touched a new high of Rs 633 on the NSE. A combined 340,000 shares changed hands on the counter in early morning deals on the NSE and BSE.
MSCI added Aurobindo Pharma to the MSCI India index after its semi-annual global index review, a Reuters report suggests.
The index provider also added 13 stocks and deleted the same number from MSCI global small-cap indexes, it added.
